Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
17%
OVERLAP
BY WEIGHT
12
# OF OVERLAPPING
HOLDINGS
BBP
67
HOLDINGS
19%
ALSO IN CANC
CANC
54
HOLDINGS
22%
ALSO IN BBP
SECTOR DRIFT (BBP minus CANC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBP |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
EXELIXIS INC | 1.7% | 3.3% | 1.7% |
|
NUVATION BIO INC CLASS A | 1.7% | 1.9% | 1.7% |
|
AMGEN INC | 1.6% | 2.2% | 1.6% |
|
SYNDAX PHARMACEUTICALS INC | 1.6% | 1.8% | 1.6% |
|
BRIDGEBIO PHARMA, INC. | 1.6% | 4.5% | 1.6% |
BBP Overweight Relative to CANC
|
DYNAVAX TECHNOLOGIES CORP | 2.2% |
|
AMICUS THERAPEUTICS INC | 2.1% |
|
IOVANCE BIOTHERAPEUTICS INC | 1.9% |
|
AXSOME THERAPEUTICS, INC. | 1.9% |
|
MIRUM PHARMACEUTICALS, INC. | 1.9% |
|
PHATHOM PHARMACEUTICALS, INC. | 1.8% |
|
DAY ONE BIOPHARMACEUTICALS, INC. | 1.7% |
|
BIOMARIN PHARMACEUTICAL INC | 1.7% |
|
TRAVERE THERAPEUTICS, INC. | 1.7% |
|
INCYTE CORP | 1.6% |
BBP Underweight Relative to CANC
|
REVOLUTION MEDICINES, INC. | -5.9% |
|
ELI LILLY & CO | -5.3% |
 |
ASTRAZENECA PLC | -4.5% |
 |
NOVARTIS AG | -4.3% |
|
ROCHE HOLDINGS LTD-SPONS ADR | -4.1% |
|
MERCK & CO. INC. | -3.9% |
 |
GENMAB A/S SPONSORED ADR | -3.7% |
|
BRISTOL-MYERS SQUIBB CO | -3.5% |
|
COGENT BIOSCIENCES INC | -3.3% |
|
NUVALENT, INC. CLASS A | -3.2% |